OXiGENE Inc (OXGN.OQ)

OXGN.OQ on NASDAQ Stock Exchange Capital Market

1.87USD
26 Nov 2014
Price Change (% chg)

$0.05 (+2.75%)
Prev Close
$1.82
Open
$1.84
Day's High
$1.87
Day's Low
$1.82
Volume
75,679
Avg. Vol
133,974
52-wk High
$5.39
52-wk Low
$1.68

OXGN.OQ

Chart for OXGN.OQ

About

OXiGENE, Inc. is a clinical-stage, biopharmaceutical company developing novel therapeutics primarily to treat cancer. The Company primary focus is the development of product candidates referred to as vascular disrupting agents (VDAs), that selectively disable and destroy abnormal blood vessels that provide solid tumors a means... (more)

Overall

Beta: 2.03
Market Cap (Mil.): $38.72
Shares Outstanding (Mil.): 20.71
Dividend: --
Yield (%): --

Financials

  OXGN.OQ Industry Sector
P/E (TTM): -- 219.87 38.74
EPS (TTM): -1.31 -- --
ROI: -61.63 -2.35 17.27
ROE: -61.63 -3.55 18.18
Search Stocks

Competitors

  Price Change
Sanofi SA (SASY.PA) €77.23 --
MediciNova, Inc. (MNOV.OQ) $3.14 +0.14
Myrexis Inc (MYRX.PK) $0.09 +0.01
Novartis AG (NOVN.VX) CHF93.00 --
Roche Holding Ltd. (ROG.VX) CHF289.90 --
Merck & Co., Inc. (MRK.N) $59.75 +0.41

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks